Targets to retard the progression of diabetic nephropathy.
Cooper
Mark E
ME
Danielle Alberti Memorial Centre for Diabetes Complications, Baker Medical Research Institute, Melbourne, Victoria, Australia. Mark.Cooper@baker.edu.au
Jandeleit-Dahm
Karin
K
Thomas
Merlin C
MC
D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology / Q000628:therapy*; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology / Q000628:therapy*; D003928:Diabetic Nephropathies / Q000503:physiopathology / Q000628:therapy*; D018450:Disease Progression; D006801:Humans